Decoupling from the Chinese pharmaceutical industry? The cost for American pharmaceutical companies may increase by half.

Recently, the US Secretary of the Treasury stated that he does not want a complete decoupling from China, but wants to bring industries such as medicine back to the United States. In response to the above statement by US officials, professionals in the Chinese pharmaceutical industry believe that a large amount of raw materials for drugs in the United States come from China; in terms of innovative drug development, Chinese companies are playing an increasingly important role. If there is a forced decoupling, the cost for some US pharmaceutical companies is expected to increase by half.